Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort.
暂无分享,去创建一个
Nigel Cox | Sam Norton | P. Williams | S. Norton | A. Young | A. Gough | J. Dixey | G. Koduri | N. Cox | Adam Young | P. Davies | J. Devlin | P. Prouse | J. Winfield | Gouri Koduri | Paul Davies | Joe Devlin | Josh Dixey | Andrew Gough | Peter Prouse | John Winfield | Peter Williams
[1] J. Dawson,et al. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis , 2002, Annals of the rheumatic diseases.
[2] G. Raghu,et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. , 1999, Chest.
[3] B. Cortet,et al. computed tomography of the lungs in patients with rheumatoid arthritis , 1997 .
[4] M. Akira,et al. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. , 1999, Journal of computer assisted tomography.
[5] J A Waldron,et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.
[6] J. Biederer,et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis , 2004, European Radiology.
[7] E. Kulinskaya,et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. , 2006, Rheumatology.
[8] K P Offord,et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[9] J. Owen,et al. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. , 1994, British journal of rheumatology.
[10] J. Dawson,et al. Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests. , 2002, Rheumatology.
[11] K. Winthrop. Serious infections with antirheumatic therapy: are biologicals worse? , 2006, Annals of the rheumatic diseases.
[12] E. Gabbay,et al. Interstitial lung disease in recent onset rheumatoid arthritis. , 1997, American journal of respiratory and critical care medicine.
[13] F. Wolfe,et al. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease , 2007, Scandinavian journal of rheumatology.
[14] J. Dawson,et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests , 2001, Thorax.
[15] A. Hansell,et al. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4) , 1999, Thorax.
[16] B. Cortet,et al. Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis , 1997, Annals of the rheumatic diseases.
[17] C. Kelly. Rheumatoid arthritis: classical rheumatoid lung disease. , 1993, Bailliere's clinical rheumatology.
[18] D. Schwartz,et al. Low-dose methotrexate may cause air trapping in patients with rheumatoid arthritis. , 1995, American journal of respiratory and critical care medicine.
[19] E. Kazerooni,et al. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. , 2005, Arthritis and rheumatism.
[20] C. Kelly,et al. Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years. , 2006, The Journal of rheumatology.
[21] R. Hubbard,et al. The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. , 2002, Rheumatology.
[22] S. Gabriel,et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years , 2003, Annals of the rheumatic diseases.
[23] M. A. van 't Hof,et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. , 1990, Annals of the rheumatic diseases.
[24] A. Young,et al. Extra-articular manifestations and complications of rheumatoid arthritis. , 2007, Best practice & research. Clinical rheumatology.
[25] F. Askin,et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. , 2001, The New England journal of medicine.
[26] D. Scott,et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. , 2006, The Journal of rheumatology.
[27] Frederick Wolfe,et al. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. , 2006, Arthritis and rheumatism.
[28] D. Schwartz,et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. , 1996, Arthritis and rheumatism.
[29] S. Brantley,et al. Lung injury linked to etanercept therapy. , 2002, Chest.
[30] I. D. Johnston,et al. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. , 1990, BMJ.
[31] K. Aho,et al. Mortality in rheumatoid arthritis. , 1995, Seminars in arthritis and rheumatism.
[32] W. Black,et al. The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.
[33] C. Beyeler,et al. Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study. , 1996, British journal of rheumatology.
[34] R. D. du Bois,et al. Genetics of fibrosing lung diseases , 2005, European Respiratory Journal.
[35] J. López-Campos,et al. Incidence of interstitial lung diseases in the south of Spain 1998–2000: The RENIA study , 2003, European Journal of Epidemiology.
[36] M. Hakala,et al. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. , 1988, Chest.
[37] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[38] A. Nicholson,et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. , 2007, American journal of respiratory and critical care medicine.
[39] C. Kelly,et al. What kills patients with rheumatoid arthritis? , 2006, Rheumatology.
[40] W. Thomson,et al. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study. , 2007, Arthritis and rheumatism.
[41] B. Burrows,et al. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.